Cervical re-screening rates continue to fall in Australia
This article was originally published in Clinica
Around one in five women in Australia underwent early cervical re-screening in 2007 after a normal Pap test, according to a report published today by the Australian Institute for Health and Welfare (AIHW).
You may also be interested in...
Oncology Center of Excellence is reviewing a research report on fluorouracil, and will next look to update cisplatin's label, but eventually must convince the reference product sponsor to submit the changes.
US FDA’s ‘Project Renewal’ requires lots of work and flexibility, Oncology Center of Excellence acknowledges. Side-benefit may be getting outside physicians to appreciate the value of drug labeling.
The pharmaceutical industry would lose bid to eliminate PUPSIT but win relaxed WFI in proposed EU GMP Annex I revision.